Genetic rare disease prevention and control: Family-based screening and reproductive interventions in Changsha
Rare diseases pose a significant public health challenge, particularly in underserved regions such as China, where genomic diagnostic services and post-diagnosis management remain limited. This study assessed the effectiveness of a rare disease screening program in Changsha, China, which enrolled 85,391 couples between January 2022 and June 2023. Among these participants were 1,414 suspected high-risk couples undergoing genetic testing, with 562 found to be at high risk of having a child with a rare disease, yielding a positive rate of 39.75%. Reproductive interventions were implemented for 319 families, successfully preventing rare disease-affected births in 141 cases. Diagnostic findings informed reproductive decision-making in 25.09% of cases and altered fertility plans in 32.74%. Machine learning analysis further revealed that participation in a parent-offspring trio and a positive family history significantly increased diagnostic likelihood, while singleton recruitment and a negative history were associated with lower diagnostic success. This pilot program highlights the value of integrating genetic diagnostics with reproductive interventions, offering a replicable model for rare disease prevention and management.
Authors
- Yue‐Qiu Tan (ORCID: https://orcid.org/0000-0002-8359-4654)
- Lanping Hu
- Zhuo-Cheng Ou (ORCID: https://orcid.org/0000-0003-0692-8670)
- Jing He (ORCID: https://orcid.org/0000-0001-5973-2335)
- Hao Hu (ORCID: https://orcid.org/0000-0001-9441-106X)
- Changgao Zhong
- Xiangyan Liu (ORCID: https://orcid.org/0009-0008-7804-6945)
- Shihao Zhou
- Xuan Song (ORCID: https://orcid.org/0000-0003-4042-7888)
- Liang Hu (ORCID: https://orcid.org/0000-0001-6351-8542)
- Xiurong Li (ORCID: https://orcid.org/0000-0001-8483-9337)
- Peng Chan (ORCID: https://orcid.org/0009-0009-8885-8522)
- J. He (ORCID: https://orcid.org/0009-0007-5323-3691)
- Wenbin He (ORCID: https://orcid.org/0000-0002-5376-5803)
- Jingjing Zhang (ORCID: https://orcid.org/0000-0002-4739-6060)
- Zhi Xu (ORCID: https://orcid.org/0000-0001-7084-3511)
- Wenqian Zhang (ORCID: https://orcid.org/0000-0003-0250-693X)
- Guangxiu Lu (ORCID: https://orcid.org/0009-0002-4732-6756)
- Lin Ge (ORCID: https://orcid.org/0000-0002-2300-6881)
- Qianjun Zhang (ORCID: https://orcid.org/0000-0002-3391-5413)
- Shu Yan (ORCID: https://orcid.org/0000-0001-7689-9233)
- Juan Du (ORCID: https://orcid.org/0000-0002-0844-5667)
- Yuankun Wang
- J. Liu (ORCID: https://orcid.org/0009-0001-8811-5309)
Institutions
- Hunan Normal University (CN)
- Changsha Hospital for Maternal and Child Health Care (CN)
Publication Details
- Journal
- Human Genetics and Genomics Advances
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1016/j.xhgg.2025.100496
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00